Parasitic diseases are major constraints in fish mariculture. The anthelmintic praziquantel
(PZQ) can effectively treat a range of flatworm parasites in a variety of fish species and has …

In September 2022, the Drug Discovery Unit at the University of Dundee, UK, organised an
international meeting at the Wellcome Collection in London to explore the current clinical …

The drug praziquantel (PZQ) is the key clinical therapy for treating schistosomiasis and other
infections caused by parasitic flatworms. A schistosome target for PZQ was recently …

Control and elimination of the parasitic disease schistosomiasis relies on mass
administration of praziquantel. Whilst these programmes reduce infection prevalence and …

Praziquantel (PZQ) is the drug of choice for the treatment of all forms of schistosomiasis,
although its mechanisms of action are not completely understood. PZQ acts largely on adult …

Diseases caused by parasitic flatworms impart a considerable healthcare burden worldwide.
Many of these diseases—for example, the parasitic blood fluke infection schistosomiasis …

Mass drug administration with praziquantel (PZQ) monotherapy is considered the mainstay
for control and elimination of the parasites causing schistosomiasis in humans. This drug …

Schistosomiasis, a severe parasitic disease, is primarily caused by Schistosoma mansoni,
Schistosoma japonicum, or Schistosoma haematobium. Currently, praziquantel is the only …

Schistosomiasis is a neglected tropical disease with more than 200 million new infections
per year. It is caused by parasites of the genus Schistosoma and can lead to death if left …

Schistosomiasis is a neglected tropical disease (NTD) caused by parasitic trematodes
belonging to the Schistosoma genus. The mainstay of schistosomiasis control is the delivery …